| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 50.689 | 66.259 | 102.255 | 0 | 30.962 | 31.882 | 41.685 | 41.957 |
| Total Income - EUR | 5.624 | 0 | 52.528 | 66.591 | 102.721 | 4 | 47.676 | 32.057 | 41.713 | 41.958 |
| Total Expenses - EUR | 1.954 | 0 | 35.435 | 48.441 | 74.718 | 42.336 | 49.594 | 27.844 | 33.280 | 32.513 |
| Gross Profit/Loss - EUR | 3.670 | 0 | 17.093 | 18.150 | 28.002 | -42.332 | -1.917 | 4.213 | 8.433 | 9.445 |
| Net Profit/Loss - EUR | 3.501 | 0 | 16.636 | 16.317 | 26.309 | -42.332 | -2.232 | 3.251 | 6.878 | 7.834 |
| Employees | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Erisbio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 1.143 | 954 | 734 | 21.837 | 21.928 |
| Current Assets | 4.635 | 0 | 61.382 | 48.245 | 67.725 | 45.079 | 48.063 | 61.367 | 77.137 | 82.549 |
| Inventories | 0 | 0 | 0 | 0 | 124 | 180 | 2.303 | 3.111 | 1.940 | 7.733 |
| Receivables | 0 | 0 | 61.274 | 45.917 | 58.081 | 39.615 | 38.806 | 54.166 | 64.597 | 53.635 |
| Cash | 4.635 | 0 | 108 | 2.327 | 9.520 | 5.284 | 6.955 | 4.089 | 10.599 | 21.181 |
| Shareholders Funds | 3.381 | 0 | 19.925 | 35.877 | 61.491 | -2.159 | -4.342 | -1.105 | 5.776 | 13.578 |
| Social Capital | 45 | 0 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.254 | 0 | 41.457 | 12.458 | 6.358 | 48.503 | 53.359 | 63.206 | 93.198 | 97.529 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5610 - 5610" | |||||||||
| CAEN Financial Year |
5610
|
|||||||||
Comments - Erisbio Srl